Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 9 years
- Director since
- 2023
9 years of board service in total across 3 boards, counting each seat separately. Longest: Incyte Corp., 3 years.
Incyte Corp.
Director
Agios Pharmaceuticals Inc.
Director
Madrigal Pharmaceuticals Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Madrigal Pharmaceuticals Inc. June 20, 202599.4%
-
Agios Pharmaceuticals Inc. June 18, 202592.1%
-
Incyte Corp. June 10, 202597.7%
-
Incyte Corp. June 12, 202497.5%
-
Incyte Corp. June 14, 202397.7%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 18, 2026 | Agios Pharmaceuticals Inc. | Option exercise | +2,816 | — | — |
| Jun 17, 2026 | Madrigal Pharmaceuticals Inc. | Grant or award | +454 | — | — |
| Jun 8, 2026 | Incyte Corp. | Grant or award | +1,642 | — | — |
| Jun 20, 2025 | Madrigal Pharmaceuticals Inc. | Grant or award | +203 | — | — |
| Jun 20, 2025 | Agios Pharmaceuticals Inc. | Option exercise | +2,120 | — | — |
| Jun 10, 2025 | Incyte Corp. | Grant or award | +2,518 | — | — |
| Apr 10, 2025 | Agios Pharmaceuticals Inc. | Open-market sale | −7,497 | $25.90 | $194,172 |
| Apr 8, 2025 | Agios Pharmaceuticals Inc. | Option exercise | +15,933 | — | — |
| Mar 10, 2025 | Madrigal Pharmaceuticals Inc. | Grant or award | +894 | — | — |
| Jun 13, 2024 | Agios Pharmaceuticals Inc. | Option exercise | +3,388 | — | — |
| Jun 12, 2024 | Incyte Corp. | Grant or award | +2,830 | — | — |
| Apr 10, 2024 | Agios Pharmaceuticals Inc. | Open-market sale | −7,791 | $27.55 | $214,642 |
| Apr 8, 2024 | Agios Pharmaceuticals Inc. | Option exercise | +15,934 | — | — |
| Jan 24, 2024 | Agios Pharmaceuticals Inc. | Open-market sale | −10,722 | $21.64 | $232,024 |
| Jan 20, 2024 | Agios Pharmaceuticals Inc. | Option exercise | +23,900 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.